Cargando…

Laboratory Investigations in Patients with Community Acquired Sepsis and/or Pneumonia Caused by Burkholderia pseudomallei

Detalles Bibliográficos
Autores principales:	Behera, Bijayini, Radhakrishnanan, Anjuna, Mishra, Baijayantimala, Mohapatra, Prasanta Raghab, Kumar, Rajesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128671/ https://www.ncbi.nlm.nih.gov/pubmed/35344934 http://dx.doi.org/10.4269/ajtmh.21-1232

Ejemplares similares

Community-Acquired burkholderia cepacia complex (BCC) pneumonia in a lung cancer patient on erlotinib
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2023)

BCG vaccination induced protection from COVID-19
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

Letter in Response to “Melioidosis in a Tertiary Care Center from South India: A 5-year Experience
por: Behera, Bijayini, et al.
Publicado: (2023)

A Case vignette of melioidosis pneumonia as Covid mimic: Role of microbiology laboratory in accurate diagnosis
por: Behera, Bijayini, et al.
Publicado: (2021)

Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases
por: Jahan, Rahat, et al.
Publicado: (2021)

Melioidosis in Children, Brazil, 1989–2019
por: Behera, Bijayini, et al.
Publicado: (2022)

In Vitro Susceptibility of Burkholderia pseudomallei Isolates to Cefiderocol and Ceftazidime/Avibactam from Odisha, India
por: Jena, Jayanti, et al.
Publicado: (2023)

Post-COVID-19 vaccination shoulder abscess and pleuroparenchymal pulmonary lesion due to Burkholderia pseudomallei()
por: Mohanty, Srujana, et al.
Publicado: (2022)

Occult drug resistance in tuberculosis: Emerging issues, upcoming challenges & possible solutions
por: Mishra, Baijayantimala, et al.
Publicado: (2020)

BCG Vaccination Policy and Protection Against COVID-19: Correspondence
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2020)

Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

Prevention of melioidosis
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2022)

Comparison of Conventional versus Molecular Semi-Quantitative Assay in Presumptive Pulmonary Tuberculosis Cases: A Study from Eastern India
por: Purohit, Geetarani, et al.
Publicado: (2020)

Burkholderia pseudomallei Laboratory Exposure, Arizona, USA
por: Speiser, Lisa J., et al.
Publicado: (2023)

Acquired bronchoesophageal fistula
por: Aggarwal, Deepak, et al.
Publicado: (2009)

Management of Accidental Laboratory Exposure to Burkholderia pseudomallei and B. mallei
por: Peacock, Sharon J., et al.
Publicado: (2008)

Genome Resequencing of Laboratory Stocks of Burkholderia pseudomallei K96243
por: Wagley, Sariqa, et al.
Publicado: (2019)

Clinical Features and Laboratory Diagnosis of Infection with the Potential Bioterrorism Agents Burkholderia Mallei and Burkholderia Pseudomallei
por: Gilad, Jacob, et al.
Publicado: (2007)

Evaluation of four sampling devices for Burkholderia pseudomallei laboratory aerosol studies
por: Schuit, Michael, et al.
Publicado: (2021)

Genome Sequence of a Burkholderia pseudomallei Clinical Isolate from a Patient with Community-Acquired Pneumonia and Septicemia
por: Mukhopadhyay, Chiranjay, et al.
Publicado: (2015)

Survival of Burkholderia pseudomallei in Water
por: Moore, Richard A, et al.
Publicado: (2008)

Detection of glycoprotein of Burkholderia pseudomallei.
por: Khrapova, N P, et al.
Publicado: (1998)

The Burkholderia pseudomallei intracellular ‘TRANSITome’
por: Heacock-Kang, Yun, et al.
Publicado: (2021)

Misidentification of Burkholderia pseudomallei, China
por: Wu, Bin, et al.
Publicado: (2021)

Pathogenicity and virulence of Burkholderia pseudomallei
por: Bzdyl, Nicole M., et al.
Publicado: (2022)

Pediatric suppurative parotitis caused by Burkholderia pseudomallei
por: Fu, Zengzhen, et al.
Publicado: (2016)

Autotransporters and Their Role in the Virulence of Burkholderia pseudomallei and Burkholderia mallei
por: Adler, Natalie R. Lazar, et al.
Publicado: (2011)

ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei
por: Harland, David N, et al.
Publicado: (2007)

Strategies for Intracellular Survival of Burkholderia pseudomallei
por: Allwood, Elizabeth M., et al.
Publicado: (2011)

Development of Vaccines Against Burkholderia Pseudomallei
por: Patel, Natasha, et al.
Publicado: (2011)

Burkholderia pseudomallei Antibodies in Children, Cambodia
por: Wuthiekanun, Vanaporn, et al.
Publicado: (2008)

Burkholderia pseudomallei Misidentified by Automated System
por: Weissert, Christoph, et al.
Publicado: (2009)

Evolution of Burkholderia pseudomallei in Recurrent Melioidosis
por: Hayden, Hillary S., et al.
Publicado: (2012)

Burkholderia pseudomallei transcriptional adaptation in macrophages
por: Chieng, Sylvia, et al.
Publicado: (2012)

Seroepidemiological surveillance of Burkholderia pseudomallei in Bangladesh
por: Maude, Rapeephan R., et al.
Publicado: (2012)

Development of Burkholderia mallei and pseudomallei vaccines
por: Silva, Ediane B., et al.
Publicado: (2013)

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014)

Presence of Burkholderia pseudomallei in the ‘Granary of Myanmar’
por: Win, Tun Tun, et al.
Publicado: (2019)

Cutaneous Melioidosis and Necrotizing Fasciitis Caused by Burkholderia pseudomallei
por: Wang, Yi-Shi, et al.
Publicado: (2003)

Erratum to: Pediatric suppurative parotitis caused by Burkholderia pseudomallei
por: Fu, Zengzhen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fp1vj81d88hpdr9obseejt63eo